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Abstract
According to the CDC, males are four times more likely to be diagnosed with autism than females. New studies
have shown that girls need a higher burden of genetic mutation to be diagnosed with autism than males. These
findings are leading researchers to a new avenue of investigation called the female protective effect. This theory
holds that even when females carry mutations in autism-linked genes, the effect of the mutations is prevented
when the level of genetic disruption is low. Understanding the biology behind this protective effect and studying
females independently from males could lead to major advancements in the prevention and treatment of ASD in
both males and females.
When I began my high school’s science research pro-
gram last year, I knew that I wanted to study autism. My
older sister Jodie was diagnosed with autism at age two,
and for 15 years, I have been called her “unaffected sib-
ling.” I have gone to walks, raised money via lemonade
stands, volunteered in respite programs for families with
kids with autism, and participated in autism research
studies at the Yale Child Study Center, but now I have
begun what I hope will be my own career as an autism
research scientist.
I have experienced firsthand the anguish autism in-
flicts on the entire family. Many kids with the condition,
including my sister, are non or minimally verbal and
have aggressive and self-injurious behaviors. The Centers
for Disease Control and Prevention (CDC) report that
40 % of those with autism are also intellectually disabled
[1]. Symptoms range from moderate to very severe, and
people with profound autism, like my sister, often need
around-the-clock care to keep them safe. Our house was
always chaotic with therapists coming and going. Night-
time was stressful and challenging, as Jodie never
seemed to need sleep. She kicked the bedroom wall we
shared and made all kinds of noises that kept everyone
in my family awake. Several times she hit or bit me un-
provoked. My parents worked out a system so that one
of them was always with her. Last year, at age 17, Jodie’s
behavior became so aggressive that she could no longer
live safely at home, and so she moved into residential
placement. Living with Jodie, and now having to live
without her, has made me desperate for answers.
In the inaugural thematic series of Molecular Autism
published earlier this year, editors Meng-Chuan Lai,
Simon Baron-Cohen, and Joseph Buxbaum acknowledge
the need to “bring sex and gender to the center stage of
autism research” [2]. According to the CDC, males show
higher rates of autism than females [1], although a por-
tion of this difference may be due to diagnosis bias [2].
As I began my high school science research classes, I
knew I wanted to focus on these gender differences be-
cause, according to Halladay and colleagues, “better un-
derstanding of sex differences could lead to major
advancements in the prevention and treatment of ASD
in both males and females” [3]. For years, researchers
looking at this gender disparity assumed that autism
must be hormone or X-chromosome linked. One study,
published by Baron-Cohen and colleagues in 2014,
showed that children who later developed autism were
exposed to elevated levels of steroid hormones, such as
testosterone, progesterone, and cortisol during the pre-
natal period, based on amniotic fluid analysis [4]. The
authors posit that because some of these hormones are
produced in much higher quantities in males than in fe-
males, this may help explain why autism is more com-
mon in males. Meanwhile, geneticists studying this
disorder found that autistic children had a consistent
pattern of de novo genetic mutations that might be
causing their condition [5–10]. As scientists discovered
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these genes, they found something surprising: girls with
autism showed a higher burden of mutation than males
with autism [5, 7, 11, 12]. Additionally, some girls with
genetic mutations did not show clinical features of aut-
ism, indicating that they had greater resistance to autism
from genetic causes than boys did [12].
These findings are leading researchers to a new avenue
of investigation called the “Female Protective Effect
(FPE).” The theory holds that this protective factor is
strong enough to shield girls who have a minimal to
moderate level of genetic disruption, but for girls with a
large genetic burden for autism, the protective factor
cannot compensate [11]. This explains why girls usually
have more severe symptoms [6, 10, 11]. For example,
Frazier et al. report that among individuals with autism
who have lower IQ, girls experience greater social com-
munication impairments than boys. Girls in this group
also have lower IQs on average than boys [13]. If a fe-
male protective factor is discovered and isolated, it could
be harnessed to protect all children from the debilitating
features of autism. I hope that the research will continue
to advance so that scientists can create a medication
mimicking the properties of the protective factor that
will alleviate everyone’s autism symptoms.
Lai, Baron-Cohen, and Buxbaum also explain that fe-
males are underrepresented in research, and therefore,
in the scientific and clinical literature [2]. In the future,
in addition to including more females, it will be import-
ant to analyze autistic females’ responses to treatment
separately from those of autistic males. Due to their
underlying genetic, biological, and brain-based differ-
ences [14], girls with autism may respond differently to
treatment than boys with autism. If males and females
are analyzed together, different responses from females
may be masked by the responses of the larger male
group. I am hoping to focus my research on looking at
treatment response differences among males and females
with autism.
I also believe that scientists can enhance their careers by
leaving the lab once in a while to interact with real people
with autism. For example, seeing my sister struggle to re-
member peoples’ names and faces enabled me to under-
stand the real impact that a social memory-enhancing
drug could have on a person’s life. Having volunteered in
a respite program for 4 years now, I have seen what the
most debilitating aspects of autism are in terms of social
functioning, and it has made me aware of the types of
medications that might be most beneficial. It is much eas-
ier to see this in people than in rats. Seeing people with
autism challenged by daily living skills can make research
designed to help them feel much more rewarding. Al-
though animal models can mimic the clinical symptoms
of autism, everyone should spend time with actual people;
people are more than the sum of their gene sequences.
Living with Jodie has taught me to appreciate hard
work and incremental improvement. When Jodie was in
applied behavior analysis (ABA) therapy for 40 hours
per week, I did not understand how difficult it must
have been for her. Therapists came and went throughout
the day, but Jodie had to stay and work with each one.
She struggled to learn concepts such as colors, shapes,
and numbers that came easily to me and to others. And
when she mastered a new skill, my family celebrated as
much as if she had been accepted to college. There are
good scientific studies supporting the value of ABA, but
it is important for scientists to continue to develop new
therapies so that kids can gain as many new skills as
possible.
The word “autism” entered my vernacular long before
I was in kindergarten, when my mom first started
explaining why my sister never answered when I spoke
to her, never let me hug her, and, in fact, seemed unable
to even look at me. When I was 3 years old, I perceived
autism as a cold that Jodie had that would eventually go
away. As I began to develop a better grasp of autism, I
felt a need to explain Jodie’s bizarre behavior to friends
and even strangers who stared at her. Now, I finally have
the opportunity to do more than simply increase aware-
ness. This summer, I began my work in autism research
as an intern at the Seaver Autism Center at the Icahn
School of Medicine at Mount Sinai Hospital. I hope
eventually to be part of the scientific research team that
discovers how the female protective factor may be the
foundation of a new treatment. Halladay and colleagues
describe that “under the FPE model, a higher rate of
ASD recurrence is expected in the siblings of affected fe-
males than the siblings of affected males, a phenomenon
often called the “Carter effect” [3]. This means that as
the sibling of a female with ASD, I was at even greater
risk for autism. I sometimes wonder why Jodie is so se-
verely affected by autism, while I am not, given that as
sisters, we may share the same risk-increasing genetic
variants. I may be able to be tested to see if I carry any
autism mutations or the protective factor, but whether
or not I turn out to be a “carrier female,” I am clearly
not an “unaffected sibling.” My experiences with Jodie
and my hopes for her future have inspired me to want
to be part of the cutting edge of discovery that will make
a difference in the lives of thousands of people.
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